Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2211-5536|3|2|60-65

ISSN： 2211-5528

Source： Current Angiogenesis, Vol.3, Iss.2, 2014-07, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

By  

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 175-178

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Cancer Therapy Updates

By  

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 954-966

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-03 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-01 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite